4 Best Detox Alternatives for React Native Testing in 2026

Forty minutes. That's the CI run time we've seen on multiple Detox pipelines teams have shared with us: simulator boot, binary build, test execution, flake retries. For a suite of 80 tests, that means a developer waiting nearly an hour to know if their pull request is clean.

That number isn't fixed. Teams that have moved off Detox typically report CI times dropping to roughly 8-12 minutes on Maestro and 6-9 minutes on Appium with pre-built binaries. The flake rate drops further still: without Detox's tight coupling to specific RN and Xcode versions, the "works on my machine, fails on CI" category of failures largely disappears.

Before we walk through the four native Detox alternatives, a brief note on Autonoma, which we build: Autonoma is a web-first E2E testing platform, so it is not a direct Detox replacement for native iOS or Android flows today. But React Native apps increasingly ship with a web surface — Expo Web builds, WebView-heavy screens, admin panels — and that web layer is where test coverage usually breaks first. If your RN project has any meaningful web surface, start with Autonoma there: agents read your codebase, generate the tests, and self-heal them when UI changes. Then pick one of the four native options below for the iOS/Android side.

There are four real Detox alternatives worth evaluating in 2026 for native RN. Which one fits your stack depends on a single decision point: your React Native variant.

Why Teams Are Moving Away from Detox

Detox is not a bad tool. But it has a specific tax that compounds over time.

The setup story alone: you need a configured macOS CI runner, Xcode Command Line Tools, a working Android SDK, the right JDK version, and a build that produces a debug binary in a predictable location. On a fresh machine that is a multi-hour process. On a shared CI environment it is a coordination problem every time the environment drifts. Pure RN apps using custom native modules add another layer of native build configuration that the Detox docs do not fully cover.

Then there is the version coupling. Detox ties to specific React Native versions. When RN releases a new architecture or Expo bumps its SDK, Detox compatibility lags. Teams on a fast release cadence sometimes find themselves blocked from upgrading RN because their Detox setup breaks with the new version, and the fix is not straightforward.

Finally, there is the flaky test problem. Detox synchronizes with the JS thread, which helps enormously - but animated transitions, network requests, and background tasks still cause timing issues that require waitFor tuning. A test suite that passes 95% of the time wastes more developer time than one that fails 100% of the time reliably.

Decision Matrix: Detox Alternative by RN Variant

Different RN setups have fundamentally different constraints. An Expo managed workflow team and a pure RN team with custom native modules face completely different tradeoffs when choosing E2E tooling.

The 4 Best Detox Alternatives

1. Maestro

Maestro has gained significant traction in the React Native ecosystem in the past two years, and for good reason. It uses a YAML-based flow syntax that reads almost like a plain-English description of what a user does. You tap a button, you type text, you assert that something is visible. No locator strategy to learn, no driver configuration to manage, no native build pipeline required.

The architecture is simple: Maestro runs outside your app and drives it through platform accessibility APIs. That means it works against any iOS Simulator or Android Emulator binary, including ones built by EAS Build. You do not need to compile a special debug build with Detox's instrumentation hooks. You point Maestro at a running app and record a flow.

Best for: Expo managed teams, small-to-mid-size pure RN teams, teams where non-engineers contribute to test coverage, and teams whose primary pain with Detox is setup and maintenance overhead rather than synchronization depth.

Pros:

• Setup takes minutes, not days. No Xcode schemes, no build configuration, no Android SDK PATH wrestling
• YAML flows are readable and writable by designers, PMs, and junior devs, not just mobile engineers
• Active community momentum in the RN E2E space, with strong Expo integration and regular releases
• Runs on CI without macOS-specific runner requirements for Android; iOS still requires macOS

Cons:

• Less synchronization depth than Detox. Complex animated transitions or heavy background processing may require manual waits
• YAML becomes verbose and hard to modularize for highly conditional test logic with many branches
• No deep native-layer access. Tests that need to assert on native OS-level behavior (permissions dialogs, push notifications, background app state) have limits

Migration effort from Detox: Low. No native build changes needed. Each Detox test rewrites to a YAML flow. Expect 30-60 minutes per flow for a straightforward migration. The CI infrastructure simplification is the biggest win.

Maestro vs Detox in practice: Maestro trades Detox's deep JS-thread synchronization for dramatically simpler setup and faster CI. For most RN teams we talk to, that tradeoff favors Maestro because the synchronization edge cases Detox handles beautifully are rare in real user journeys, while the setup and maintenance burden hits every single PR.

For a deeper comparison, see our Detox vs Appium breakdown which covers where Maestro sits relative to both.

2. Appium

Appium is the industry's cross-platform mobile testing workhorse. It speaks WebDriver protocol, which means your team can use JavaScript, Python, Java, Ruby, or C# to write tests. It covers iOS and Android with the same framework, integrates with every major cloud device farm (BrowserStack, Sauce Labs, AWS Device Farm), and has been battle-tested against production apps at scale for over a decade.

Appium 2 modernized the architecture significantly. The monolithic server is gone; drivers are now installed as plugins, which means you only install what you need. The iOS XCUITest driver and Android UiAutomator2 driver are stable and maintained. If you have Appium experience already or a large existing test library in a language other than JavaScript, migration costs are lower than starting fresh.

Best for: Teams that need a large device matrix (real devices across OS versions), teams already using Appium for web testing who want to unify on one framework, pure RN teams with complex cross-platform coverage requirements, and teams integrating with cloud device farms that have first-class Appium support. For a deeper look, see our Appium alternatives guide.

Pros:

• Broadest cross-platform coverage in the market. iOS, Android, web, and desktop from one framework
• Language-agnostic. Teams that already write tests in Java or Python do not need to switch languages
• Deep cloud device farm integration. BrowserStack, Sauce Labs, and AWS Device Farm all have first-class Appium support
• Mature plugin ecosystem. Element caching, image comparison, and gesture libraries are well-maintained

Cons:

• Still carries Appium's traditional setup complexity, though Appium 2 improved this meaningfully
• Slower than Maestro and Detox. The WebDriver protocol layer adds overhead that compounds across large test suites
• More verbose test authoring. Appium tests require explicit driver setup, capability configuration, and session management that Maestro abstracts away

Migration effort from Detox: Medium. The concepts map reasonably well (both drive apps from outside through platform accessibility APIs), but the test syntax is different and CI infrastructure needs reconfiguration. Expect 1-2 hours per test for a careful migration.

3. Playwright

Playwright is the wrong tool for most React Native apps and the right tool for a specific subset. If your RN codebase targets web via Expo Web, or if significant portions of your app run inside a WebView component, Playwright is the best option in this list for that surface area.

Where Playwright excels: full browser DevTools integration, network request interception and mocking, visual snapshot testing, and a developer experience that is genuinely best-in-class for web-based testing. It does not require a mobile simulator. It runs against any browser or web URL. For Expo Router projects where the web build is a real deployment target, Playwright covers that target with no friction.

Where Playwright stops: it cannot drive a native iOS Simulator or Android Emulator. It has no concept of a mobile gesture model, a camera permission dialog, or a push notification. If your app is primarily native with only minor web content, Playwright is not an E2E replacement for Detox.

Best for: Expo Web apps, Expo Router projects with web targets, apps with heavy WebView content, and teams that want unified browser testing across their web and hybrid surfaces. For where E2E fits alongside unit and integration coverage, see our testing pyramid guide.

Pros:

• Best-in-class developer experience and debugging tools for web surfaces
• Network mocking and interception built-in, which is uniquely powerful for API-heavy RN apps that use WebView
• Zero simulator setup. Runs anywhere Node.js runs, including Linux CI runners
• Pairs naturally with Maestro in an Expo Router project: Maestro for native, Playwright for web

Cons:

• Cannot test native iOS or Android. This is an architectural boundary, not a missing feature
• Visual testing outputs need storage and diffing infrastructure to be useful at scale
• Not a standalone Detox replacement for teams with pure native RN apps

Migration effort from Detox: N/A for native tests. Playwright does not replace native Detox flows; it covers a different surface. The effort is additive: you add Playwright for web coverage rather than migrating existing Detox tests to it.

4. Detox on EAS Build

If your team is already deep in the Expo ecosystem and your primary pain with Detox is the "I can't get a clean binary out of my setup" part of the pipeline, running Detox against an EAS-built binary is worth considering before switching test tools entirely.

The pattern is concrete. Detox does not support Expo's managed flow directly, because Detox requires a release-mode build with the JavaScript bundle compiled in (not a Metro-served dev bundle). EAS Build can produce exactly that: a custom development client or debug profile that bundles the JS into the binary. You write a build profile in eas.json, point EAS Build at it, collect the resulting .app or .apk, and run Detox against it. Test execution itself still happens wherever your CI runs: GitHub Actions, CircleCI, or Expo's own EAS Workflows (which can orchestrate end-to-end pipelines but primarily documents Maestro as the E2E tool).

This gives Expo bare and managed teams a reproducible way to keep Detox tests without wrestling with native build configuration themselves. The authoring model stays the same. The part you offload is the binary-production step that used to be the brittle part.

Best for: Expo bare or managed teams already using EAS Build, teams that value Detox's synchronization depth but are primarily frustrated by building Detox-compatible binaries locally, and teams that want to avoid migrating an existing Detox test suite off Detox entirely.

Pros:

• Offloads the binary-build step to EAS, which is the part most teams struggle to configure
• Keeps the full Detox test authoring model. Existing tests run without rewriting
• Tight coupling with EAS Build, so your test binary is the same artifact flow your users get
• No ejection required from Expo managed workflow to run Detox against an EAS-built binary

Cons:

• You still own the test-execution side (runners, simulators, device coordination) unless you use EAS Workflows
• Still requires writing Detox tests. If the authoring model is your pain point, this does not help
• Does not solve Detox version coupling with RN upgrades; you still hit the same compatibility ceiling
• Expo's own docs now lean toward Maestro for E2E on EAS Workflows, which is a signal worth reading

Migration effort from Detox: Low. You are primarily changing how the binary gets built, not the tests. The effort is configuration work within eas.json and your CI. For how CI time and flakiness drive the real cost of E2E infrastructure, see our flaky tests CI/CD cost analysis.

Cost at Scale

Test infrastructure cost compounds as your suite grows. Here is how the four alternatives compare when you are running 200+ test cases across iOS and Android on every PR:

The hidden cost in every row is engineer time. A Detox setup that breaks during a React Native upgrade costs 1-2 days of a senior engineer's time. That cost does not appear in a CI bill but it is real. Teams running 3-4 major RN upgrades per year with a brittle Detox suite are paying that tax repeatedly.

How to Choose

The decision comes down to three questions. First, what is your RN variant? The matrix above gives you a shortlist. Second, what is your actual pain (setup complexity, maintenance burden, flakiness, speed, or coverage gaps)? Different tools address different pains. Maestro addresses setup complexity. Detox on EAS Build addresses the binary-production step without forcing a full framework switch. Playwright addresses the web surface coverage gap. Third, how much migration budget do you have? Migrating off Detox mid-sprint is risky. Low-migration-effort options (Maestro, Detox on EAS Build) carry less risk than high-effort ones (Appium full rewrite).

If your team is running Expo managed workflow and needs the best Detox alternative for Expo without ejecting or configuring native builds, start with Maestro. If you need cross-platform device farm coverage at scale, Appium is the right investment. If your app has a meaningful Expo Web surface, add Playwright alongside whatever native tool you choose, and if you need a managed web E2E layer on top of that web surface, Autonoma covers it without hand-authoring. If you are already on EAS Build and like Detox but struggle to get a clean test binary, keeping Detox and building via EAS is the least disruptive path.